← k3vl4r
Log inGet started →

TAK (Takeda Pharmaceutical Co ADR) Price Forecast

AI-generated price forecast for Takeda Pharmaceutical Co ADR (TAK) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's calibrated AI forecast currently reads TAK as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 19.76. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

19.76

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

TAK forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+19.61%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called TAK's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest TAK news

From the market-news feed the forecasts are read against.

  • Japan's first female PM says makeup and housework add hours to her working day · ldr:euronews.com · Oct 16
  • Reported Earlier, Takeda Launches ORZEYFUL In Japan And China As First-In-Class Orexin Agonist For Narcolepsy Type 1, With US Launch Set For Next Month After DEA Scheduling · Benzinga · Oct 14
  • Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1 · Yahoo · Oct 14
  • Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 2026 · Yahoo · Oct 14
  • Takeda Remains A Buy, Boosted By Recent Narcolepsy Drug Approval And Robust Pipeline · SeekingAlpha · Oct 13

🔒

See the full TAK forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

TAK forecast — frequently asked

Will TAK go up?

K3vl4r's calibrated AI forecast currently reads TAK as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the TAK price prediction for 2026?

K3vl4r's model projects TAK toward $23.53 over the next ~4 weeks, a +19.6% move from $19.67. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

SENSMGTXNBPGOSSONMDSGRYVCYTCTKBRXSTCLYMAHCOTNYASLSENOV

Will TAK reach…?

Will TAK reach $25.00?Will TAK reach $50.00?Will TAK reach $100.00?

Or see the full TAK price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare TAK

TAK vs SENSTAK vs MGTXTAK vs NBPTAK vs GOSSTAK vs ONMDTAK vs SGRY

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.